Regulatory and Washington

Study: NAFTA withdrawal would mean fewer retail jobs, higher consumer prices
Withdrawing from the North American Free Trade Agreement would cost retailers and consumers up to $16 billion a year and lead to the loss of 128,000 retail-related jobs over the next three years, according a recently released study prepared for the National Retail Federation, the Retail Industry Leaders Association and the Food Marketing Institute.
AAM praises generics’ role in Trump pricing plan
In a move that’s considered an “important step forward for patients coping with skyrocketing health care costs,” Association for Accessible Medicines president and CEO Chester “Chip” Davis, Jr., praised President Trump for making clear in his remarks on Friday the important role that generic and biosimilar medicines play in containing prescription drug costs for patients.

Iowa Gov. Kim Reynolds signs bipartisan opioid bill into law

In an effort to battle the opioid epidemic, Iowa is tackling the issue of doctor shopping and over-prescribing in the state with a bipartisan piece of legislation signed Monday by Gov. Kim Reynolds.
Medical marijuana clinical research gains momentum in Pennsylvania

The Pennsylvania Department of Health has approved eight universities as Certified Academic Clinical Research Centers in the state’s medical marijuana program, signaling the first step towards clinical research to commence in the commonwealth.
Colorado becomes 16th state to mandate DXM age restriction

In 2012, California became the first state to prohibit sales of DXM-containing products to minors.
Trump outlines plan to lower drug prices

The industry is responding favorably to President Donald Trump's plan to lower drug prices by focusing on increasing competition, improving negotiating tools, incentivizing lower list prices and lowering out-of-pocket costs.
OTC monograph reform clears House, Senate committees

The current OTC regulatory framework requires notice and comment rulemaking, an increasingly slow administrative process.
E-prescribing bills have banner week

On Capitol Hill, the Every Prescription Conveyed Securely Act cleared the House Energy and Commerce Committee, and in Tennessee, Gov. Bill Haslam signed a bill into law that will require e-prescribing for controlled substances on or after Jan. 1, 2020.
Hawaii takes steps to protect coral reefs with sunscreen ban

The state recently became the first in the United States to pass a bill banning the distribution of sunscreens that contain the harmful chemicals oxybenzone and octinoxate.
H-E-B’s Otto brings insights to World Health Congress

H-E-B COO and former NACDS chairman Martin Otto participated in a keynote panel at the World Healthcare Congress, in which he discussed high healthcare spending as a barrier to improved patient health over time.

Study: NAFTA withdrawal would mean fewer retail jobs, higher consumer prices

AAM praises generics’ role in Trump pricing plan

Iowa Gov. Kim Reynolds signs bipartisan opioid bill into law

Medical marijuana clinical research gains momentum in Pennsylvania

Colorado becomes 16th state to mandate DXM age restriction

Trump outlines plan to lower drug prices

OTC monograph reform clears House, Senate committees

E-prescribing bills have banner week

Hawaii takes steps to protect coral reefs with sunscreen ban

H-E-B’s Otto brings insights to World Health Congress